Primary Immunodeficiency Diseases
7
1
2
3
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
14.3%
1 terminated out of 7 trials
75.0%
-11.5% vs benchmark
29%
2 trials in Phase 3/4
100%
3 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (7)
Study of BP-SCIG 20% in Patients With Primary Immunodeficiency (PID)
Haploidentical Hematopoietic Cell Transplantation Using TCR Alpha/Beta and CD19 Depletion
Evaluation of an IgG Deficiency Rapid Screening Test: A Performance Study With Primary Immunodeficiency (PID) Patients in Tunisia
Developing a Screening Tool for Primary Immunodeficiency Disease (PID) in Pakistan
Exercise Capacity, Physical Activity Level and Quality of Life in Children With Primary Immunodeficiency
CD34+ Stem Cell Infusion to Augment Graft Function
A Study of NewGam, Human Immunoglobulin 10%, in Patients With Primary Immunodeficiency Diseases